Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2014-003408-65Phase 3Unknown
Phase 3, randomised trial of ulipristal in hypermenorrhea and Fibromyoma (LM) (2 arms), sponsored by University of Edinburgh. Primary endpoint: Menorrhagia Multi-Attribute Scale at 12 months. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2014-003408-65.